What the Research Shows So Far BPC-157 has been studied for over two decades in animal models and preclinical studies, with consistent findings across a wide range of tissues and systems: BPC-157 has shown an extremely high safety margin in rodents, with no toxicity or organ damage reported even at doses much higher than those typically used in humans. Sikiric, P
Donating blood can temporarily affect your A1C measurements
Does BPC-157 interact with liver medications
Amjad S, Nisar S, Bhat AA, Shah AR, Frenneaux MP, Fakhro K, et al
Tirzepatide, while FDA-approved for weight loss, was not included because the recency of that approval limited the data available for analysis